Comparison of carbamazepine rash in multiple sclerosis and epilepsy

Acta Neurologica Scandinavica

Volumn 125, Issue 1, 2012, Pages 60-63

  Shirzadi, M ^a   Alvestad, S ^a   Hovdal, H ^b   Espeset, K ^b   Lydersen, S ^a   Brodtkorb, E ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Carbamazepine; Epilepsy; Gender; Multiple sclerosis; Rash

Indexed keywords

CARBAMAZEPINE;

ADULT; AGE; ALLERGY; ARTICLE; CONTROLLED STUDY; DRUG ERUPTION; EPILEPSY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDY; SKIN MANIFESTATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PAIN; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84155189226     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01553.x     Document Type: Article

References (22)

1. Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007;48:1360-5.
2. Alvestad S, Lydersen S, Brodtkorb E. Cross-reactivity pattern of rash from current aromatic antiepileptic drugs. Epilepsy Res 2008;80:194-200.
3. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-44.
4. Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Curr Opin Neurol 2009;22:144-9.
5. Arif H, Buchsbaum R, Weintraub D et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9.
6. Wang XQ, Lang SY, Shi XB, Tian HJ, Wang RF, Yang F. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population. Seizure 2010;19:562-6.
7. Somers EC, Thomas SL, Smeeth L, Hall AJ. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol 2009;169:749-55.
8. Mackay IR. Clustering and commonalities among autoimmune diseases. J Autoimmun 2009;33:170-7.
9. Frøvig AG, Presthus J, Sponheim N. The significance of allergy in the etiology and pathogenesis of multiple sclerosis. Acta Neurol Scand 1967;43:215-27.
10. Alonso A, Hernán MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008;117:15-20.
11. Pedotti R, Farinotti M, Falcone C et al. Allergy and multiple sclerosis: a population-based case-control study. Mult Scler 2009;15:899-906.
12. Monteiro L, Souza-Machado A, Menezes C, Melo A. Association between allergies and multiple sclerosis: a systematic review and meta-analysis. Acta Neurol Scand 2011;123:1-7.
13. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitive syndrome. Incidence, prevention and management. Drug Saf 1999;6:489-501.
14. Invernizzi P, Gershwin ME. The genetics of human autoimmune disease. J Autoimmun 2009;33:290-9.
15. Kaufman DW, Kelly JP, Anderson T, Harmon DC, Shapiro S. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997;38:1265-9.
16. Nasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 2008;49:438-45.
17. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411-23.
18. Koutsouraki E, Costa V, Baloyannis S. Epidemiology of multiple sclerosis in Europe: a review. Int Rev Psychiatry 2010;22:2-13.
19. Link J, Lorentzen AR, Kockum I et al. Two HLA class I genes independently associated with multiple sclerosis. J Neuroimmunol 2010;226:172-6.
20. Solaro C, Brichetto G, Battaglia MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci 2005;25:307-10.
21. P-Codrea Tigaran S, Sidenius P, Dam M. Lamotrigine-induced rash - worth a rechallenge. Acta Neurol Scand 2005;111:191-4.
22. Chadwick D, Shaw MD, Foy P, Rawlins MD, Turnbull DM. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol Neurosurg Psychiatry 1984;47:642-4.